<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管出版物</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U -NV u8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac&amp;utm_source =镀铬<description>心血管亮点：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 10 月 25 日，星期三 12:14:48 +0000</lastbuilddate><pubDate> Wed, 25 Oct 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>组合饮食评分和心血管疾病风险：3 项前瞻性队列研究的结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/37877288/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>结论：在 3 个大型前瞻性队列中，PDS 与较低的 CVD（包括 CHD 和中风）风险以及更有利的血脂和炎症状况相关。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 10 月 25 日。doi：10.1161/CIRCULATIONAHA.123.065551。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：基于植物的组合饮食模式包括公认的降胆固醇食物（即植物蛋白、坚果、粘性纤维、植物甾醇和植物单不饱和脂肪），随机对照试验显示这些食物可以改善多种心血管疾病 (CVD) 危险因素。关于长期坚持饮食和 CVD 风险的作用的证据有限。主要目的是检查组合饮食评分 (PDS) 与总 CVD、冠心病 (CHD) 和心血管疾病 (CHD) 风险之间的关系。中风。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们前瞻性地追踪了护士健康研究（1984-2016）中的 73924 名女性、护士健康研究 II（1991-2017）中的 92346 名女性以及卫生专业人员随访研究（1986-2016）中的 43970 名男性基线时没有 CVD 或癌症。在基线时使用经过验证的食物频率调查问卷评估饮食，并每 4 年使用 PDS 对植物蛋白（豆类）、坚果和种子、粘性纤维来源、植物甾醇（毫克/天）和植物进行积极排名单不饱和脂肪来源，并对饱和脂肪和胆固醇含量高的食物进行负面评价。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在长达 30 年的随访期间，记录了 16917 例 CVD 病例，其中包括 10666 例 CHD 病例和 6473 例中风。在对因素和修改后的替代健康饮食指数（排除重叠成分）进行多变量调整后，将最高值与在最低的五分位数中，PDS 较高的参与者的总 CVD 风险较低（汇总风险比 [HR]，0.86 [95% CI，0.81-0.92]； <i>P</i><sub>趋势</sub>&lt;0.001）、CHD（汇总 HR，0.86 [95%] CI，0.80-0.93]； <i>P</i><sub>趋势</sub>=0.0001）和中风（汇总 HR，0.86 [95% CI，0.78-0.95]； <i>P</i><sub>趋势</sub>=0.0003）。此外，较高 25% 的 PDS 与较低的 PDS 相关。总 CVD 风险（汇总 HR，0.92 [95% CI，0.89-0.95]）、CHD（汇总 HR，0.92 [95% CI，0.88-0.95]）和卒中风险（汇总 HR，0.92 [95% CI，0.87] -0.96]）。敏感性和大多数亚组分析的结果保持一致，并且没有证据表明 CVD、CHD 或中风偏离线性。在一部分参与者中，较高的 PDS 与更有利的血脂和炎症特征。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在 3 个大型前瞻性队列中，PDS 与较低的 CVD（包括 CHD 和中风）风险以及更有利的血脂和炎症状况相关。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37877288/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37877288</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065551>10.1161/CIRCULATIONAHA.123.065551</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37877288</guid><pubDate> Wed, 25 Oct 2023 06:00:00 -0400</pubDate><dc:creator>安德里亚·J·格伦</dc:creator><dc:creator>玛尔塔·瓜什-费雷</dc:creator><dc:creator>瓦桑蒂·S·马利克</dc:creator><dc:creator>西里尔·WC·肯德尔</dc:creator><dc:creator>乔安·E·曼森</dc:creator><dc:creator>埃里克·B·里姆</dc:creator><dc:creator>沃尔特·C·威利特</dc:creator><dc:creator>孙琪</dc:creator><dc:creator>大卫·詹金斯</dc:creator><dc:creator>弗兰克·胡</dc:creator><dc:creator>约翰·L·西文派珀</dc:creator><dc:date>2023-10-25</dc:date><dc:source>循环</dc:source><dc:title>组合饮食评分和心血管疾病风险：3 项前瞻性队列研究的结果</dc:title><dc:identifier>下午：37877288</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065551</dc:identifier></item><item><title>心力衰竭患者缺铁的定义</title><link/>https://pubmed.ncbi.nlm.nih.gov/37875635/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol。2023 年 10 月 24 日。doi：10.1038/s41569-023-00951-6。印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37875635/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37875635</a> | DOI： <a href=https://doi.org/10.1038/s41569-023-00951-6>10.1038/s41569-023-00951-6</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37875635</guid><pubDate> Tue, 24 Oct 2023 06:00:00 -0400</pubDate><dc:creator>约翰·GF·克莱兰</dc:creator><dc:date>2023-10-24</dc:date><dc:source> 《自然》评论、心脏病学</dc:source><dc:title>心力衰竭患者缺铁的定义</dc:title><dc:identifier>下午:37875635</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00951-6</dc:identifier></item><item><title>群体免疫预测 SARS-CoV-2 的进化轨迹</title><link/>https://pubmed.ncbi.nlm.nih.gov/37875109/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description> SARS-CoV-2 病毒的大规模进化以遗传进化枝的快速更替为标志。新变种显示出内在变化、传播性增加以及减少先前感染或疫苗接种引起的交叉免疫的抗原变化。变异对全球进化的影响仍不清楚。在这里，我们建立了 SARS-CoV-2 的预测适应性模型，该模型集成了抗原选择和内在选择。该模型通过跟踪... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 10 月 11 日：S0092-8674(23)01076-0. doi: 10.1016/j.cell.2023.09.022. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> SARS-CoV-2 病毒的大规模进化以遗传进化枝的快速更替为标志。新变种显示出内在变化、传播性增加以及减少先前感染或疫苗接种引起的交叉免疫的抗原变化。变异对全球进化的影响仍不清楚。在这里，我们建立了 SARS-CoV-2 的预测适应度模型，该模型集成了抗原选择和内在选择。该模型通过跟踪时间分辨序列数据、流行病学记录和交叉中和数据来提供信息我们的推论表明，免疫压力，包括疫苗接种和既往感染的贡献，已成为驱动 SARS-CoV-2 最近进化的主导力量。适应度模型可以通过两种方式服务于持续监测。首先，它成功地预测循环菌株的短期进化，并标记可能取代先前主要变体的新兴变体。其次，它在成功逃逸变体出现之前预测其可能的抗原谱。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37875109/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37875109</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.09.022>10.1016/j.cell.2023.09.022</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37875109</guid><pubDate> Tue, 24 Oct 2023 06:00:00 -0400</pubDate><dc:creator>马蒂斯·梅杰斯</dc:creator><dc:creator>丹尼斯·鲁赫内维茨</dc:creator><dc:creator>简·埃伯哈特</dc:creator><dc:creator>玛尔塔·武克萨</dc:creator><dc:creator>迈克尔·拉斯格</dc:creator><dc:date>2023-10-24</dc:date><dc:source>细胞</dc:source><dc:title>群体免疫预测 SARS-CoV-2 的进化轨迹</dc:title><dc:identifier>下午:37875109</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.09.022</dc:identifier></item><item><title> JAK2 的人类 MCTS1 依赖性翻译对于分枝杆菌的 IFN-γ 免疫至关重要</title><link/>https://pubmed.ncbi.nlm.nih.gov/37875108/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>人类遗传性干扰素-γ (IFN-γ) 免疫性疾病是严重分枝杆菌疾病的基础。我们报告了来自不同血统（来自中国、芬兰、伊朗和沙特阿拉伯）的分枝杆菌疾病男性的 X 连锁隐性 MCTS1 缺陷。完整这种翻译重新启动因子的缺乏会损害蛋白质子集的翻译，包括所有测试的细胞类型（包括 T 淋巴细胞和吞噬细胞）中的激酶 JAK2。JAK2 表达... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 10 月 18 日：S0092-8674(23)01078-4. doi: 10.1016/j.cell.2023.09.024. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">人类遗传性干扰素-γ (IFN-γ) 免疫性疾病是严重分枝杆菌疾病的基础。我们报告了来自不同血统（来自中国、芬兰、伊朗和沙特阿拉伯）的分枝杆菌疾病男性的 X 连锁隐性 MCTS1 缺陷。完整该翻译重新启动因子的缺乏会损害蛋白质子集的翻译，包括所有测试细胞类型（包括 T 淋巴细胞和吞噬细胞）中的激酶 JAK2。JAK2 表达足够低，会损害细胞对白细胞介素 23 (IL-23) 的反应) 和部分 IL-12，但不包括其他 JAK2 依赖性细胞因子。对 IL-23 的缺陷反应优先损害分枝杆菌攻击后先天性适应性粘膜相关不变 T 细胞 (MAIT) 和 γδ T 淋巴细胞产生 IFN-γ令人惊讶的是，缺乏 MCTS1 依赖的翻译重新启动和核糖体回收似乎在这些患者中在生理上是多余的。这些发现表明，X 连锁隐性人类 MCTS1 缺陷通过损害先天样适应性 T 中的 JAK2 翻译而成为孤立的分枝杆菌疾病的基础。淋巴细胞，从而损害 IL-23 依赖性的 IFN-γ 诱导。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37875108/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37875108</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.09.024>10.1016/j.cell.2023.09.024</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37875108</guid><pubDate> Tue, 24 Oct 2023 06:00:00 -0400</pubDate><dc:creator>乔纳森·博伦</dc:creator><dc:creator>周钦华</dc:creator><dc:creator>昆汀·菲利普</dc:creator><dc:creator>大岸正人</dc:creator><dc:creator>达拉万·林猜</dc:creator><dc:creator>蒂·涅米宁</dc:creator><dc:creator>西敏·塞耶普尔</dc:creator><dc:creator>尼玛·帕尔瓦内</dc:creator><dc:creator>尼玛·雷扎伊</dc:creator><dc:creator>尼卢法·亚兹丹帕纳</dc:creator><dc:creator>玛娜·莫梅尼兰迪</dc:creator><dc:creator>克莱门特·科尼尔</dc:creator><dc:creator>安娜·莱娜·尼胡斯</dc:creator><dc:creator>卡尔丁·施密特</dc:creator><dc:creator>卡洛斯·阿兰戈·佛朗哥</dc:creator><dc:creator>汤姆·勒沃耶</dc:creator><dc:creator>陶希夫·汗</dc:creator><dc:creator>杨瑞</dc:creator><dc:creator>朱莉娅·普坎</dc:creator><dc:creator>露西娅·埃拉佐</dc:creator><dc:creator>米科拉·罗尤克</dc:creator><dc:creator>塔贾·瓦托维克</dc:creator><dc:creator>扎拉·詹达</dc:creator><dc:creator>伊万·巴加里奇</dc:creator><dc:creator>玛丽·马特纳</dc:creator><dc:creator>阿德里安·热维斯</dc:creator><dc:creator>李海伦</dc:creator><dc:creator>杰瑞米·罗桑</dc:creator><dc:creator>杰西卡·N·皮尔</dc:creator><dc:creator>约安·西勒斯纳</dc:creator><dc:creator>韩智恩</dc:creator><dc:creator>安妮-索菲·荣誉者</dc:creator><dc:creator>马塞拉·蒙卡达·贝莱斯</dc:creator><dc:creator>玛尔塔·马丁·费尔南德斯</dc:creator><dc:creator>迈克尔·E·霍雷什</dc:creator><dc:creator>塔蒂亚娜·科切特科夫</dc:creator><dc:creator>莫妮卡·施密特</dc:creator><dc:creator>穆罕默德·A·谢赫里</dc:creator><dc:creator>伊娃·萨洛</dc:creator><dc:creator>哈里萨克森</dc:creator><dc:creator>格哈德·艾尔·加扎里</dc:creator><dc:creator>艾哈迈德·亚蒂姆</dc:creator><dc:creator>卡米尔·苏黛</dc:creator><dc:creator>费代丽卡·萨卢斯托</dc:creator><dc:creator>阿明·恩瑟</dc:creator><dc:creator>尼科·马尔</dc:creator><dc:creator>张鹏</dc:creator><dc:creator>杜桑·博古诺维奇</dc:creator><dc:creator>奥雷利·科巴特</dc:creator><dc:creator>穆罕默德·沙鲁伊</dc:creator><dc:creator>维维安·贝齐亚特</dc:creator><dc:creator>洛朗·阿贝尔</dc:creator><dc:creator>王晓川</dc:creator><dc:creator>斯蒂芬妮·布瓦松-杜普伊斯</dc:creator><dc:creator>奥雷里奥·泰勒曼</dc:creator><dc:creator>杰辛塔·布斯塔曼特</dc:creator><dc:creator>张谦</dc:creator><dc:creator>让·洛朗·卡萨诺瓦</dc:creator><dc:date>2023-10-24</dc:date><dc:source>细胞</dc:source><dc:title>JAK2 的人类 MCTS1 依赖性翻译对于分枝杆菌的 IFN-γ 免疫至关重要</dc:title><dc:identifier>下午:37875108</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.09.024</dc:identifier></item><item><title> Amulet 或 Watchman 装置用于经皮左心耳封堵术后的一年结果：SWISS-APERO 随机临床试验的预先指定分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37875064/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 10 月 24 日。doi：10.1161/CIRCULATIONAHA.123.067599。印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37875064/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37875064</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067599>10.1161/CIRCULATIONAHA.123.067599</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37875064</guid><pubDate> Tue, 24 Oct 2023 06:00:00 -0400</pubDate><dc:creator>罗伯托·加莱亚</dc:creator><dc:creator>尼古拉斯·梅内沃</dc:creator><dc:creator>费德里科·德·马可</dc:creator><dc:creator>阿德尔·阿米尼安</dc:creator><dc:creator>迪克·赫格</dc:creator><dc:creator>康斯坦蒂娜·查尔库</dc:creator><dc:creator>克里斯托夫·格拉尼</dc:creator><dc:creator>弗雷德里克·安塞尔姆</dc:creator><dc:creator>安娜·弗兰佐内</dc:creator><dc:creator>帕斯卡·弗兰克斯</dc:creator><dc:creator>乌尔斯·费舍尔</dc:creator><dc:creator>弗朗西斯科·贝多尼</dc:creator><dc:creator>洛伦兹·雷伯</dc:creator><dc:creator>马可·瓦尔吉米利</dc:creator><dc:date>2023-10-24</dc:date><dc:source>循环</dc:source><dc:title>Amulet 或 Watchman 装置用于经皮左心耳封堵术后的一年结果：SWISS-APERO 随机临床试验的预先指定分析</dc:title><dc:identifier>下午：37875064</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.067599</dc:identifier></item><item><title>经导管肺 SAPIEN 3 瓣膜植入的结果：国际登记</title><link/>https://pubmed.ncbi.nlm.nih.gov/37874971/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>结论：SAPIEN 3 TPVI 对 CHD 患者的治疗效果良好，其中一半患者有天然或修补的 RVOT。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 年 10 月 24 日：ehad663。doi：10.1093/eurheartj/ehad663。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景和目的：经导管肺动脉瓣植入 (TPVI) 用于治疗与先天性心脏病 (CHD) 相关的右心室流出道 (RVOT) 功能障碍。EUROPULMS3 研究了未充分记录的 TPVI 与 SAPIEN 3 瓣膜的结果SAPIEN 3-TPVI 注册表。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在来自 15 个国家 35 个中心的观察队列中，对患者相关、程序和随访结果数据进行回顾性评估。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：获得了 2014 年至 2021 年连续接受治疗的 840 名患者的数据，中位年龄为 29.2 (19.0-41.6) 岁。最常见的诊断是圆锥干缺损 (70.5%)，其中 50.7% 患有天然或修补的 RVOT瓣膜尺寸分别为 20、23、26 和 29 毫米，占 0.4%、25.5%、32.1% 和 42.0% 的患者。瓣膜植入成功率为 98.5% [95% 置信区间 (CI)，97.4% -99.2%] 的患者。中位随访时间为 20.3 (7.1-38.4) 个月。8 名患者经历了感染性心内膜炎；11 名患者需要肺动脉瓣置换术，较大瓣膜的发生率较低 (P = .009)，4 名患者经历了肺动脉瓣置换术瓣膜血栓，其中 1 例死亡，3 例经抗凝治疗康复。TPVI 后 1 年、3 年和 6 年的累积发生率 (95%CI) 如下：感染性心内膜炎，0.5% (0.0%-1.0%)、0.9% ( 0.2%-1.6%) 和 3.8% (0.0%-8.4%)；肺动脉瓣置换术 0.4% (0.0%-0.8%)、1.3% (0.2%-2.4%) 和 8.0% (1.2%-14.8) %）；肺动脉瓣血栓形成分别为0.4%（0.0%-0.9%）、0.7%（0.0%-1.3%）和0.7%（0.0%-1.3%）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：SAPIEN 3 TPVI 对 CHD 患者的治疗效果良好，其中一半患者有天然或修补的 RVOT。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37874971/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37874971</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad663>10.1093/eurheartj/ehad663</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37874971</guid><pubDate> Tue, 24 Oct 2023 06:00:00 -0400</pubDate><dc:creator>塞巴斯蒂安·哈斯科特</dc:creator><dc:creator>詹姆斯·R·边沁</dc:creator><dc:creator>卢卡·朱尼奥</dc:creator><dc:creator>佩德罗·贝特里安-布拉斯科</dc:creator><dc:creator>亚历山大·肯普尼</dc:creator><dc:creator>阿里胡伊杰</dc:creator><dc:creator>海萨姆·巴霍</dc:creator><dc:creator>希夫·拉杰·夏尔马</dc:creator><dc:creator>马修·琼斯</dc:creator><dc:creator>埃尔兹别塔·卡塔齐娜·比尔纳卡</dc:creator><dc:creator>尼古拉斯·库姆斯</dc:creator><dc:creator>斯坦尼米尔·格奥尔基耶夫</dc:creator><dc:creator>海伦·布瓦伊斯特</dc:creator><dc:creator>何塞·迪奥戈·马丁斯</dc:creator><dc:creator>马里诺斯·坎齐斯</dc:creator><dc:creator>马克·特纳</dc:creator><dc:creator>斯蒂芬·舒伯特</dc:creator><dc:creator>扎卡里亚·贾拉尔</dc:creator><dc:creator>吉安弗兰科·布特拉</dc:creator><dc:creator>索菲·马雷克扎德-米拉尼</dc:creator><dc:creator>埃斯蒂巴利兹·巴尔德奥尔米洛斯</dc:creator><dc:creator>克莱门特·卡森蒂</dc:creator><dc:creator>安德·奥德米斯</dc:creator><dc:creator>菲利普·阿尔德伯特</dc:creator><dc:creator>尼古拉斯·哈斯</dc:creator><dc:creator>伊哈卜·哈提布</dc:creator><dc:creator>哈坎·沃兰德</dc:creator><dc:creator>詹皮耶罗·盖奥</dc:creator><dc:creator>阿尔贝托·门多萨</dc:creator><dc:creator>萨伊卡·阿里夫</dc:creator><dc:creator>比亚吉奥·卡斯塔尔迪</dc:creator><dc:creator>高特·多伦</dc:creator><dc:creator>罗纳德·G·卡雷尔</dc:creator><dc:creator>玛丽亚·赫苏斯·德尔·塞罗-马林</dc:creator><dc:creator>欧文·基茨米勒</dc:creator><dc:creator>安东尼·赫尔穆兹</dc:creator><dc:creator>马里奥·卡米纳蒂</dc:creator><dc:creator>帕特里斯·盖兰</dc:creator><dc:creator>安雅·腾格勒</dc:creator><dc:creator>阿兰·弗赖斯</dc:creator><dc:creator>EUROPUMS3 调查员</dc:creator><dc:date>2023-10-24</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>经导管肺 SAPIEN 3 瓣膜植入的结果：国际登记</dc:title><dc:identifier>下午:37874971</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad663</dc:identifier></item><item><title>心房颤动患者同时进行左心耳封堵和经导管主动脉瓣置换术</title><link/>https://pubmed.ncbi.nlm.nih.gov/37874908/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>结论：对于患有 AF 的严重主动脉瓣狭窄患者，同时 WATCHMAN LAAO 和 TAVR 并不劣于 TAVR 联合药物治疗。当同时 LAAO 被视为 AF 患者药物治疗的替代方案时，应考虑联合手术增加的复杂性和风险。经导管主动脉瓣置换术。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 10 月 24 日。doi：10.1161/CIRCULATIONAHA.123.067312。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：心房颤动 (AF) 在接受经导管主动脉瓣置换术 (TAVR) 的患者中很常见，并且与出血和中风风险增加相关。而左心耳封堵术 (LAAO) 被批准作为抗凝剂的替代药物，用于预防患者中风对于 AF，无论是在严重 AS 患者中放置这些装置，还是与 TAVR 同时放置，都已得到广泛研究。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：WATCH-TAVR 是一项多中心、随机试验，评估 AF 患者同时进行 TAVR 和 LAAO 与 WATCHMAN 的安全性和有效性。患者按 1:1 随机分配至 TAVR+LAAO 或 TAVR+药物治疗。WATCHMAN 患者接受 45 天的抗凝治疗。随后进行双联抗血小板治疗直至 6 个月。对于随机接受 TAVR+药物治疗的患者，抗凝治疗是根据治疗医生的偏好。主要非劣效性终点是两种策略之间 2 年的全因死亡率、中风和大出血。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：该研究于2017年12月至2020年11月期间在美国34个中心入组了349名患者，其中177名患者接受TAVR+LAAO治疗，172名患者接受TAVR+药物治疗。平均年龄为81岁，CHA <sub>2</sub> DS <sub>2</sub> -VASc评分为4.9，HAS -BLED 评分为 3.0。基线时，85.4% 的患者正在接受抗凝治疗，71.3% 的患者正在接受抗血小板治疗。队列的基线特征非常平衡。增量 LAAO 手术时间为 38 分钟；中位造影剂体积为 119联合手术为 70 mL，单独 TAVR 为 70 mL。24 个月随访时，TAVR+LAAO 中分别有 82.5% 和 50.8% 的患者接受了任何抗血小板治疗，13.9% 和 66.7% 的患者接受了任何抗凝治疗对于复合主要终点，TAVR+.LAAO 不劣于 TAVR+ 药物治疗（TAVR+LAAO 和 TAVR+药物治疗分别为 22.7 次事件/100 患者年和 27.3 次事件/100 患者年；风险比 0.86， 95% CI 0.60 -1.22，P<sub>非劣效性</sub>&lt;0.001）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：对于患有 AF 的严重主动脉瓣狭窄患者，同时 WATCHMAN LAAO 和 TAVR 并不劣于 TAVR 联合药物治疗。当同时 LAAO 被视为 AF 患者药物治疗的替代方案时，应考虑联合手术增加的复杂性和风险。经导管主动脉瓣置换术。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37874908/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37874908</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067312>10.1161/CIRCULATIONAHA.123.067312</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37874908</guid><pubDate> Tue, 24 Oct 2023 06:00:00 -0400</pubDate><dc:creator>萨米尔·R·卡帕迪亚</dc:creator><dc:creator>阿马尔·克里希纳斯瓦米</dc:creator><dc:creator>布赖恩·惠森南特</dc:creator><dc:creator>斯里尼瓦萨·波特鲁里</dc:creator><dc:creator>维杰·艾耶</dc:creator><dc:creator>约瑟夫·阿拉贡</dc:creator><dc:creator>菲利普·吉迪恩</dc:creator><dc:creator>贾斯汀·斯特罗特</dc:creator><dc:creator>罗伯特·莱昂纳迪</dc:creator><dc:creator>希曼舒·阿加瓦尔</dc:creator><dc:creator>德国拉瑞恩</dc:creator><dc:creator>卡洛斯·桑切斯</dc:creator><dc:creator>西达克帕尔·S·帕纳奇</dc:creator><dc:creator>詹姆斯·哈维</dc:creator><dc:creator>托斯顿·瓦尔</dc:creator><dc:creator>维努·梅农</dc:creator><dc:creator>凯西·沃尔斯基</dc:creator><dc:creator>王秋庆</dc:creator><dc:creator>马丁·B·莱昂</dc:creator><dc:date>2023-10-24</dc:date><dc:source>循环</dc:source><dc:title>心房颤动患者同时进行左心耳封堵和经导管主动脉瓣置换术</dc:title><dc:identifier>下午:37874908</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.067312</dc:identifier></item><item><title>英格兰和威尔士正在进行阶段性姑息治疗的功能性单心室疾病再次干预的危险因素：一项回顾性队列研究</title><link/>https://pubmed.ncbi.nlm.nih.gov/37871240/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 24 日；148(17):1343-1345.doi: 10.1161/CIRCULATIONAHA.123.065647. Epub 2023 年 10 月 23 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37871240/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37871240</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10589421/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">PMC10589421</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065647>10.1161/CIRCULATIONAHA.123.065647</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37871240</guid><pubDate> Mon, 23 Oct 2023 06:00:00 -0400</pubDate><dc:creator>黄奇</dc:creator><dc:creator>黛博拉·里杜特</dc:creator><dc:creator>曾伟德</dc:creator><dc:creator>奈杰尔·E·德鲁里</dc:creator><dc:creator>蒂莫西·J·琼斯</dc:creator><dc:creator>汉娜·贝尔沙姆-雷维尔</dc:creator><dc:creator>埃琳娜·哈吉科斯塔</dc:creator><dc:creator>安娜·西尔</dc:creator><dc:creator>切坦·梅塔</dc:creator><dc:creator>克里斯蒂娜·佩格尔</dc:creator><dc:creator>索尼娅·克罗</dc:creator><dc:creator>费兰·埃斯普尼-普霍尔</dc:creator><dc:creator>罗德尼·CG·富兰克林</dc:creator><dc:creator>凯特·L·布朗</dc:creator><dc:date>2023-10-23</dc:date><dc:source>循环</dc:source><dc:title>英格兰和威尔士正在进行阶段性姑息治疗的功能性单心室疾病再次干预的危险因素：一项回顾性队列研究</dc:title><dc:identifier>下午:37871240</dc:identifier><dc:identifier> PMC：PMC10589421</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065647</dc:identifier></item><item><title>经导管瓣膜介入时代心脏外科培训的未来</title><link/>https://pubmed.ncbi.nlm.nih.gov/37871239/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 24 日；148(17):1295-1297。doi: 10.1161/CIRCULATIONAHA.123.064793。Epub 2023 年 10 月 23 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37871239/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37871239</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064793>10.1161/循环AHA.123.064793</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37871239</guid><pubDate> Mon, 23 Oct 2023 06:00:00 -0400</pubDate><dc:creator>格里·达勒</dc:creator><dc:creator>塔拉勒·阿塔西</dc:creator><dc:creator>金子刚</dc:creator><dc:date>2023-10-23</dc:date><dc:source>循环</dc:source><dc:title>经导管瓣膜介入时代心脏外科培训的未来</dc:title><dc:identifier>下午:37871239</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064793</dc:identifier></item><item><title>心脏外科领域的女性：缩小公平差距</title><link/>https://pubmed.ncbi.nlm.nih.gov/37871238/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 24 日；148(17):1292-1294.doi: 10.1161/CIRCULATIONAHA.123.063656. Epub 2023 年 10 月 23 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37871238/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37871238</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.063656>10.1161 / CIRCULATIONAHA.123.063656</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37871238</guid><pubDate> Mon, 23 Oct 2023 06:00:00 -0400</pubDate><dc:creator>鲍比·柳川</dc:creator><dc:creator>玛丽娜·易卜拉欣</dc:creator><dc:creator>詹妮弗·劳顿</dc:creator><dc:date>2023-10-23</dc:date><dc:source>循环</dc:source><dc:title>心脏外科领域的女性：缩小公平差距</dc:title><dc:identifier>下午：37871238</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.063656</dc:identifier></item><item><title>定量流量比对于选择桡动脉移植靶血管的潜力：一项回顾性观察研究</title><link/>https://pubmed.ncbi.nlm.nih.gov/37871237/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 24 日；148(17):1340-1342. doi: 10.1161/CIRCULATIONAHA.123.065494. Epub 2023 年 10 月 23 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37871237/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37871237</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065494>10.1161/循环AHA.123.065494</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37871237</guid><pubDate> Mon, 23 Oct 2023 06:00:00 -0400</pubDate><dc:creator>詹虎</dc:creator><dc:creator>王春元</dc:creator><dc:creator>鑫源</dc:creator><dc:creator>张思雨</dc:creator><dc:creator>陈思鹏</dc:creator><dc:creator>侯志辉</dc:creator><dc:creator>徐波</dc:creator><dc:creator>雷松</dc:creator><dc:creator>于宁</dc:creator><dc:creator>张艳</dc:creator><dc:creator>魏峰</dc:creator><dc:date>2023-10-23</dc:date><dc:source>循环</dc:source><dc:title>定量流量比对于选择桡动脉移植靶血管的潜力：一项回顾性观察研究</dc:title><dc:identifier>下午:37871237</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065494</dc:identifier></item><item><title> 2023年心血管外科期刊简介</title><link/>https://pubmed.ncbi.nlm.nih.gov/37871236/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 24 日；148(17):1287-1288. doi: 10.1161/CIRCULATIONAHA.123.067002. Epub 2023 年 10 月 23 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37871236/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37871236</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067002>10.1161/循环AHA.123.067002</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37871236</guid><pubDate> Mon, 23 Oct 2023 06:00:00 -0400</pubDate><dc:creator>马克·鲁尔</dc:creator><dc:creator>迈克尔·P·菲施贝因</dc:creator><dc:creator>詹姆斯·A·德·莱莫斯</dc:creator><dc:date>2023-10-23</dc:date><dc:source>循环</dc:source><dc:title>2023年心血管外科期刊简介</dc:title><dc:identifier>下午：37871236</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.067002</dc:identifier></item><item><title>替格瑞洛单药治疗接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的安全性和有效性：TWILIGHT 和 TICO 随机试验的个体患者数据荟萃分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37870970/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>背景：对于接受经皮冠状动脉介入治疗 (PCI) 的急性冠状动脉综合征 (ACS) 患者，推荐使用强效 P2Y(12) 抑制剂联合阿司匹林进行双联抗血小板治疗 (DAPT) 1 年。 12) 短期 DAPT 后抑制剂已成为一种减少出血的策略。方法：我们汇集了来自随机试验的个体患者数据，其中包括接受 PCI 治疗的 ACS 患者，并采用初始... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 10 月 23 日。doi：10.1161/CIRCULATIONAHA.123.067283。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><b>背景：</b>对于接受经皮冠状动脉介入治疗 (PCI) 的冠状动脉急性综合征 (ACS) 患者，推荐使用强效 P2Y <sub>12</sub>抑制剂联合阿司匹林为期 1 年的双联抗血小板治疗 (DAPT)。或者，在术后使用 P2Y <sub>12</sub>抑制剂单药治疗<b>方法：</b>我们汇总了来自随机试验的个体患者数据，这些随机试验包括接受 PCI 治疗的 ACS 患者，最初接受 3 个月的 DAPT 疗程，然后接受替格瑞洛单药治疗，对比继续替格瑞洛加阿司匹林治疗。 PCI 后前 3 个月内持续发生重大缺血或出血事件被排除在分析之外。主要结局是出血学术研究联盟 (BARC) 3 型或 5 型出血发生在索引 PCI 后 3 至 12 个月之间。关键次要终点是死亡、心肌梗塞 (MI) 或中风的复合数据。危险比 (HR) 和 95% 置信区间 (CI) 是使用 Cox 回归和一阶段方法生成的，旨在治疗人群。<b>结果：</b>合并队列(N = 7,529) 的特征是平均年龄为 62.8 岁，23.2% 的患者为女性，55% 的患者患有生物标志物阳性 ACS。在 3 至 12 个月之间，与替格瑞洛联合治疗相比，替格瑞洛单药治疗显着减少了 BARC 3 或 5 出血阿司匹林（0.8% vs. 2.1%；HR 0.37，95% CI 0.24-0.56；p &lt; 0.001）。全因死亡、心肌梗死或中风的发生率在各组之间没有显着差异（2.4% vs. 2.7%；HR 0.91，95% CI 0.68-1.21；P = 0.515)。在生物标志物阳性 ACS 患者中，结果没有变化。<b>结论：</b>在接受 PCI 且已完成 3 个月 DAPT 疗程的 ACS 患者中，停用阿司匹林，然后接受替格瑞洛单药治疗与替格瑞洛联合阿司匹林相比，可减少大出血，且不会显着增加缺血风险。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37870970/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37870970</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067283>10.1161/CIRCULATIONAHA.123.067283</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37870970</guid><pubDate> Mon, 23 Oct 2023 06:00:00 -0400</pubDate><dc:creator>乌斯曼·巴贝尔</dc:creator><dc:creator>张良洙</dc:creator><dc:creator>安吉洛·奥利瓦</dc:creator><dc:creator>曹大卫</dc:creator><dc:creator>比尔吉特·沃格尔</dc:creator><dc:creator>乔治·丹加斯</dc:creator><dc:creator>萨曼莎·萨托里</dc:creator><dc:creator>亚历山德罗·斯皮里托</dc:creator><dc:creator>肯尼思·F·史密斯</dc:creator><dc:creator>马蒂亚·布兰卡</dc:creator><dc:creator>蒂莫西·科利尔</dc:creator><dc:creator>斯图尔特·波科克</dc:creator><dc:creator>马可·瓦尔吉米利</dc:creator><dc:creator>金秉国</dc:creator><dc:creator>洪明基</dc:creator><dc:creator>罗克珊娜·迈赫兰</dc:creator><dc:date>2023-10-23</dc:date><dc:source>循环</dc:source><dc:title>替格瑞洛单药治疗接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的安全性和有效性：TWILIGHT 和 TICO 随机试验的个体患者数据荟萃分析</dc:title><dc:identifier>下午:37870970</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.067283</dc:identifier></item><item><title>微管介导的衰竭心脏中 β&lt;sub>;2&lt;/sub>;AR 翻译和功能的调节</title><link/>https://pubmed.ncbi.nlm.nih.gov/37869877/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>结论：不对称的微管依赖性运输决定了健康心肌细胞微管中 β(1)AR 和 β(2)AR 的定位差异，这是质膜上 2 个 β-AR 独特区隔的基础。定位模式在心肌梗死后发生了改变。 ，由 T 管重塑引起，导致 β(2)AR 介导的环单磷酸腺苷信号传导扭曲。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 10 月 23 日。doi：10.1161/CIRCRESAHA.123.323174。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：β1 肾上腺素能受体 (β <sub>1</sub> AR) 和 Beta-2 肾上腺素能受体 (β <sub>2</sub> AR) 介导的环单磷酸腺苷信号对心脏功能和心力衰竭进展具有明显影响。然而，调节空间定位和功能的机制心脏 β-AR 的区室划分仍然难以捉摸。新出现的证据表明，mRNP（信使核糖核蛋白）的微管依赖性运输和局部蛋白质翻译调节心肌细胞中的蛋白质区室划分。我们发现心肌细胞中的 β-AR 区室划分是通过选择性运输其 mRNA 来完成的和本地化翻译。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：采用单分子荧光原位杂交和亚细胞纳米活检技术研究大鼠心肌细胞中β-AR mRNA的定位模式，利用长春花碱研究微管对β-AR mRNA定位的作用，并探讨其对受体定位和功能的影响。用免疫荧光和高通量福斯特共振能量转移显微镜进行评估。mRNA 蛋白共检测分析鉴定了心肌细胞中可能的 β-AR 翻译位点。通过单分子荧光阐明了 β-AR mRNA 在心力衰竭后重新分布的机制对心肌梗死后 16 周和去管心肌细胞进行原位杂交、纳米活检和高通量福斯特共振能量转移显微镜检查。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：β <sub>1</sub> AR 和 β <sub>2</sub> AR mRNA 在心肌细胞中显示出不同的定位，其中 β <sub>1</sub> AR 在核周区域发现，而 β <sub>2</sub> AR 在整个细胞中显示弥散分布。微管的破坏导致 β <sub>2</sub> AR 转录物向核周区域转移β <sub>2</sub> AR 转录物和翻译蛋白之间的紧密接近表明翻译过程发生在专门的、精确定义的细胞区室中。β <sub>2</sub> AR 转录物的重新分布是微管依赖性的，因为微管解聚显着减少了在衰竭的心脏中，β <sub>1</sub> AR 和 β <sub>2</sub> AR mRNA 均向细胞外周重新分布，类似于在经历药物诱导去管的心肌细胞中所观察到的情况。这表明 T 管重塑有助于 β-AR mRNA 重新分布，并且衰竭心脏中β <sub>2</sub> AR 功能受损。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：不对称微管依赖性运输决定了健康心肌细胞微管中 β <sub>1</sub> AR 和 β <sub>2</sub> AR 定位的差异，这是质膜上 2 个 β-AR 独特区隔的基础。定位模式在心肌梗死后发生了改变，这是由于 t -肾小管重塑，导致<sub>β2</sub> AR 介导的环单磷酸腺苷信号传导扭曲。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37869877/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37869877</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.123.323174>10.1161/CIRCRESAHA.123.323174</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37869877</guid><pubDate> Mon, 23 Oct 2023 06:00:00 -0400</pubDate><dc:creator>关佐伊</dc:creator><dc:creator>比诺·P·纳达普拉姆</dc:creator><dc:creator>梁曼顿</dc:creator><dc:creator>亚历山大·康德拉绍夫</dc:creator><dc:creator>萨尼卡·莫哈冈卡尔</dc:creator><dc:creator>敖力</dc:creator><dc:creator>库穆图·阿马拉达萨</dc:creator><dc:creator>吉晨</dc:creator><dc:creator>斯蒂芬·罗瑟里</dc:creator><dc:creator>伊约贝尔·基布雷布</dc:creator><dc:creator>付家荣</dc:creator><dc:creator>何塞·桑切斯·阿隆索</dc:creator><dc:creator>凯瑟琳·曼斯菲尔德</dc:creator><dc:creator>哈里哈兰·萨勃拉曼尼安</dc:creator><dc:creator>彼得·T·赖特</dc:creator><dc:creator>帕梅拉·斯维亚特洛斯卡</dc:creator><dc:creator>维亚切斯拉夫·尼古拉耶夫</dc:creator><dc:creator>贝亚塔·沃伊恰克·斯托哈德</dc:creator><dc:creator>亚历山大·P·伊万诺夫</dc:creator><dc:creator>约书亚·埃德尔</dc:creator><dc:creator>朱莉娅·戈雷利克</dc:creator><dc:date>2023-10-23</dc:date><dc:source>流通研究</dc:source><dc:title>微管介导的衰竭心脏中 β&lt;sub>;2&lt;/sub>;AR 翻译和功能的调节</dc:title><dc:identifier>下午：37869877</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.323174</dc:identifier></item><item><title>生物膜样结核分枝杆菌索的机械病理学</title><link/>https://pubmed.ncbi.nlm.nih.gov/37865090/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231025081447&amp;v=2.17.9.post6+86293ac<description>结核分枝杆菌 (Mtb) 在无洗涤剂的情况下进行轴生培养，形成生物膜样条带，这是毒力的临床标志。在芯片肺 (LoC) 和小鼠模型中，肺泡细胞中的条带有助于通过核压缩抑制先天免疫信号传导。 , 细胞外索导致接触依赖性吞噬细胞死亡，但在上皮细胞之间的细胞间生长。这些机械病理学机制的缺乏解释了肺泡... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 10 月 11 日：S0092-8674(23)01037-1。doi：10.1016/j.cell.2023.09.016。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Mycobacterium tuberculosis (Mtb) cultured axenically without detergent forms biofilm-like cords, a clinical identifier of virulence. In lung-on-chip (LoC) and mouse models, cords in alveolar cells contribute to suppression of innate immune signaling via nuclear compression. Thereafter, extracellular cords cause contact-dependent phagocyte death but grow intercellularly between epithelial cells. The absence of these mechanopathological mechanisms explains the greater proportion of alveolar lesions with increased immune infiltration and dissemination defects in cording-deficient Mtb infections. Compression of Mtb lipid monolayers induces a phase transition that enables mechanical energy storage. Agent-based simulations demonstrate that the increased energy storage capacity is sufficient for the formation of cords that maintain structural integrity despite mechanical perturbation. Bacteria in cords remain translationally active despite antibiotic exposure and regrow rapidly upon cessation of treatment. This study provides a conceptual framework for the biophysics and function in tuberculosis infection and therapy of cord architectures independent of mechanisms ascribed to single bacteria.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37865090/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37865090</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.09.016>10.1016/j.cell.2023.09.016</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37865090</guid><pubDate> Sat, 21 Oct 2023 06:00:00 -0400</pubDate><dc:creator> Richa Mishra</dc:creator><dc:creator> Melanie Hannebelle</dc:creator><dc:creator> Vishal P Patil</dc:creator><dc:creator> Anaëlle Dubois</dc:creator><dc:creator> Cristina Garcia-Mouton</dc:creator><dc:creator> Gabriela M Kirsch</dc:creator><dc:creator> Maxime Jan</dc:creator><dc:creator> Kunal Sharma</dc:creator><dc:creator> Nicolas Guex</dc:creator><dc:creator> Jessica Sordet-Dessimoz</dc:creator><dc:creator> Jesus Perez-Gil</dc:creator><dc:creator> Manu Prakash</dc:creator><dc:creator> Graham W Knott</dc:creator><dc:creator> Neeraj Dhar</dc:creator><dc:creator> John D McKinney</dc:creator><dc:creator> Vivek V Thacker</dc:creator><dc:date> 2023-10-21</dc:date><dc:source> Cell</dc:source><dc:title> Mechanopathology of biofilm-like Mycobacterium tuberculosis cords</dc:title><dc:identifier> pmid:37865090</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.09.016</dc:identifier></item><item><title> De novo protein identification in mammalian sperm using in situ cryoelectron tomography and AlphaFold2 docking</title><link/> https://pubmed.ncbi.nlm.nih.gov/37865089/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac<description> To understand the molecular mechanisms of cellular pathways, contemporary workflows typically require multiple techniques to identify proteins, track their localization, and determine their structures in vitro. Here, we combined cellular cryoelectron tomography (cryo-ET) and AlphaFold2 modeling to address these questions and understand how mammalian sperm are built in situ. Our cellular cryo-ET and subtomogram averaging provided 6.0-Å reconstructions of axonemal microtubule structures. The... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Oct 19:S0092-8674(23)01038-3. doi: 10.1016/j.cell.2023.09.017. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> To understand the molecular mechanisms of cellular pathways, contemporary workflows typically require multiple techniques to identify proteins, track their localization, and determine their structures in vitro. Here, we combined cellular cryoelectron tomography (cryo-ET) and AlphaFold2 modeling to address these questions and understand how mammalian sperm are built in situ. Our cellular cryo-ET and subtomogram averaging provided 6.0-Å reconstructions of axonemal microtubule structures. The well-resolved tertiary structures allowed us to unbiasedly match sperm-specific densities with 21,615 AlphaFold2-predicted protein models of the mouse proteome. We identified Tektin 5, CCDC105, and SPACA9 as novel microtubule-associated proteins. These proteins form an extensive interaction network crosslinking the lumen of axonemal doublet microtubules, suggesting their roles in modulating the mechanical properties of the filaments. Indeed, Tekt5 -/- sperm possess more deformed flagella with 180° bends. Together, our studies presented a cellular visual proteomics workflow and shed light on the in vivo functions of Tektin 5.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37865089/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37865089</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.09.017>10.1016/j.cell.2023.09.017</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37865089</guid><pubDate> Sat, 21 Oct 2023 06:00:00 -0400</pubDate><dc:creator> Zhen Chen</dc:creator><dc:creator> Momoko Shiozaki</dc:creator><dc:creator> Kelsey M Haas</dc:creator><dc:creator> Will M Skinner</dc:creator><dc:creator> Shumei Zhao</dc:creator><dc:creator> Caiying Guo</dc:creator><dc:creator> Benjamin J Polacco</dc:creator><dc:creator> Zhiheng Yu</dc:creator><dc:creator> Nevan J Krogan</dc:creator><dc:creator> Polina V Lishko</dc:creator><dc:creator> Robyn M Kaake</dc:creator><dc:creator> Ronald D Vale</dc:creator><dc:creator> David A Agard</dc:creator><dc:date> 2023-10-21</dc:date><dc:source> Cell</dc:source><dc:title> De novo protein identification in mammalian sperm using in situ cryoelectron tomography and AlphaFold2 docking</dc:title><dc:identifier> pmid:37865089</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.09.017</dc:identifier></item><item><title> Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction</title><link/> https://pubmed.ncbi.nlm.nih.gov/37864782/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Oct 21;44(40):4203-4207. doi: 10.1093/eurheartj/ehad706.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37864782/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37864782</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad706>10.1093/eurheartj/ehad706</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37864782</guid><pubDate> Sat, 21 Oct 2023 06:00:00 -0400</pubDate><dc:creator> Filippo Crea</dc:creator><dc:date> 2023-10-21</dc:date><dc:source> European heart journal</dc:source><dc:title> Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction</dc:title><dc:identifier> pmid:37864782</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad706</dc:identifier></item><item><title> Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial</title><link/> https://pubmed.ncbi.nlm.nih.gov/37864578/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Oct 21:ehad639. doi: 10.1093/eurheartj/ehad639. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37864578/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37864578</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad639>10.1093/eurheartj/ehad639</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37864578</guid><pubDate> Sat, 21 Oct 2023 06:00:00 -0400</pubDate><dc:creator> Ambarish Pandey</dc:creator><dc:creator> Ahmed A Kolkailah</dc:creator><dc:creator> Francesco Cosentino</dc:creator><dc:creator> Christopher P Cannon</dc:creator><dc:creator> Robert C Frederich</dc:creator><dc:creator> David ZI Cherney</dc:creator><dc:creator> Samuel Dagogo-Jack</dc:creator><dc:creator> Richard E Pratley</dc:creator><dc:creator> Nilo B Cater</dc:creator><dc:creator> Ira Gantz</dc:creator><dc:creator> James P Mancuso</dc:creator><dc:creator> Darren K McGuire</dc:creator><dc:date> 2023-10-21</dc:date><dc:source> European heart journal</dc:source><dc:title> Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial</dc:title><dc:identifier> pmid:37864578</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad639</dc:identifier></item><item><title> Liquid-biopsy proteomics combined with AI identifies cellular drivers of eye aging and disease in vivo</title><link/> https://pubmed.ncbi.nlm.nih.gov/37863056/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac<description> Single-cell analysis in living humans is essential for understanding disease mechanisms, but it is impractical in non-regenerative organs, such as the eye and brain, because tissue biopsies would cause serious damage. We resolve this problem by integrating proteomics of liquid biopsies with single-cell transcriptomics from all known ocular cell types to trace the cellular origin of 5,953 proteins detected in the aqueous humor. We identified hundreds of cell-specific protein markers, including... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Oct 6:S0092-8674(23)01033-4. doi: 10.1016/j.cell.2023.09.012. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Single-cell analysis in living humans is essential for understanding disease mechanisms, but it is impractical in non-regenerative organs, such as the eye and brain, because tissue biopsies would cause serious damage. We resolve this problem by integrating proteomics of liquid biopsies with single-cell transcriptomics from all known ocular cell types to trace the cellular origin of 5,953 proteins detected in the aqueous humor. We identified hundreds of cell-specific protein markers, including for individual retinal cell types. Surprisingly, our results reveal that retinal degeneration occurs in Parkinson&#39;s disease, and the cells driving diabetic retinopathy switch with disease stage. Finally, we developed artificial intelligence (AI) models to assess individual cellular aging and found that many eye diseases not associated with chronological age undergo accelerated molecular aging of disease-specific cell types. Our approach, which can be applied to other organ systems, has the potential to transform molecular diagnostics and prognostics while uncovering new cellular disease and aging mechanisms.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37863056/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37863056</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.09.012>10.1016/j.cell.2023.09.012</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37863056</guid><pubDate> Fri, 20 Oct 2023 06:00:00 -0400</pubDate><dc:creator> Julian Wolf</dc:creator><dc:creator> Ditte K Rasmussen</dc:creator><dc:creator> Young Joo Sun</dc:creator><dc:creator> Jennifer T Vu</dc:creator><dc:creator> Elena Wang</dc:creator><dc:creator> Camilo Espinosa</dc:creator><dc:creator> Fabio Bigini</dc:creator><dc:creator> Robert T Chang</dc:creator><dc:creator> Artis A Montague</dc:creator><dc:creator> Peter H Tang</dc:creator><dc:creator> Prithvi Mruthyunjaya</dc:creator><dc:creator> Nima Aghaeepour</dc:creator><dc:creator> Antoine Dufour</dc:creator><dc:creator> Alexander G Bassuk</dc:creator><dc:creator> Vinit B Mahajan</dc:creator><dc:date> 2023-10-20</dc:date><dc:source> Cell</dc:source><dc:title> Liquid-biopsy proteomics combined with AI identifies cellular drivers of eye aging and disease in vivo</dc:title><dc:identifier> pmid:37863056</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.09.012</dc:identifier></item><item><title> Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement</title><link/> https://pubmed.ncbi.nlm.nih.gov/37862595/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093/eurheartj/ehad683. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37862595/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37862595</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad683>10.1093/eurheartj/ehad683</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37862595</guid><pubDate> Fri, 20 Oct 2023 06:00:00 -0400</pubDate><dc:creator> Łukasz Kalińczuk</dc:creator><dc:creator> Wiktor Skotarczak</dc:creator><dc:creator> Lars Sondergaard</dc:creator><dc:creator> Gary S Mintz</dc:creator><dc:date> 2023-10-20</dc:date><dc:source> European heart journal</dc:source><dc:title> Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement</dc:title><dc:identifier> pmid:37862595</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad683</dc:identifier></item><item><title> Deep learning approach to unmask hidden salt effects in the era of artificial intelligence</title><link/> https://pubmed.ncbi.nlm.nih.gov/37862594/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231025081447&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Oct 20:ehad673. doi: 10.1093/eurheartj/ehad673. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37862594/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231025081447&v=2.17.9.post6+86293ac">37862594</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad673>10.1093/eurheartj/ehad673</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37862594</guid><pubDate> Fri, 20 Oct 2023 06:00:00 -0400</pubDate><dc:creator> Athanasios J Manolis</dc:creator><dc:creator> Manolis S Kallistratos</dc:creator><dc:date> 2023-10-20</dc:date><dc:source> European heart journal</dc:source><dc:title> Deep learning approach to unmask hidden salt effects in the era of artificial intelligence</dc:title><dc:identifier> pmid:37862594</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad673</dc:identifier></item></channel></rss>